Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF in Premature Ovarian Insufficiency
NCT06117982Phase 2Completed
- Sponsor
- Trio Fertility
- Start
- Oct 2023
- Primary completion
- May 2025
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of filgrastim in premature ovarian insufficiency (POI), sponsored by Trio Fertility. Started Oct 2023; status: completed.
02
Drugs
filgrastim
03
Conditions
premature ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT06117982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06117982.